MagAssist

company

About

MagAssist is a special expert of the National Youth Thousand People Program and a special professor of Suzhou University.

  • 101 - 250

Details

Last Funding Type
Series B
Last Funding Money Raised
¥100M
Industries
Health Care,Medical
Founded date
Jan 1, 2017
Number Of Employee
101 - 250
Operating Status
Active

Suzhou Xinqing Medical Technology Co., Ltd. was founded in 2017 by Dr. Xu Bozhen, a special expert of the National Youth Thousand People Program and a special professor of Suzhou University. He is a high-tech enterprise with the main goal of developing the world's leading in vitro short-term ventricular assist device (in vitro artificial heart). . The core members of the company's entrepreneurial team are the world's top artificial heart engineering technology experts. With years of experience in overseas artificial heart research and development and productization, the company has developed a domestically produced artificial heart with independent intellectual property rights.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
¥600M
MagAssist has raised a total of ¥600M in funding over 2 rounds. Their latest funding was raised on Oct 18, 2021 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 18, 2021 Series C ¥500M 2 Detail
Jan 14, 2021 Series B ¥100M 2 Detail

Investors

Number of Lead Investors
Number of Investors
4
MagAssist is funded by 4 investors. Cenova Capital and CH Innovations are the most recent investors.
Investor Name Lead Investor Funding Round
Cenova Capital Series C
CH Innovations Series C
Anji Yunshuo Series B
Tigeryeah Capital Series B